ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · IEX Real-Time Price · USD
0.0809
+0.0024 (3.06%)
At close: Jul 26, 2024, 3:54 PM
0.0789
-0.0020 (-2.47%)
After-hours: Jul 26, 2024, 7:28 PM EDT
ENDRA Life Sciences Market Cap
ENDRA Life Sciences has a market cap or net worth of $5.61 million as of July 26, 2024. Its market cap has decreased by -43.85% in one year.
Market Cap
5.61M
Enterprise Value
4.80M
1-Year Change
-43.85%
Ranking
Category
Stock Price
$0.08
Market Cap Chart
Since June 30, 2017, ENDRA Life Sciences's market cap has decreased from $15.20M to $5.61M, a decrease of -63.06%. That is a compound annual growth rate of -13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 900.00K | -94.97% |
| Dec 29, 2023 | 17.90M | 38.76% |
| Dec 30, 2022 | 12.90M | -55.82% |
| Dec 31, 2021 | 29.20M | 55.32% |
| Dec 31, 2020 | 18.80M | 49.21% |
| Dec 31, 2019 | 12.60M | 55.56% |
| Dec 31, 2018 | 8.10M | -57.37% |
| Dec 29, 2017 | 19.00M | 25.00% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 5.86M |
| PolyPid | 5.80M |
| IM Cannabis | 5.75M |
| Biomerica | 5.72M |
| Innovative Eyewear | 5.61M |
| Adial Pharmaceuticals | 5.55M |
| Aethlon Medical | 5.54M |
| Ainos | 5.48M |